Specgx Llc Drug Patent Portfolio

Specgx Llc owns 2 orange book drugs protected by 3 US patents Given below is the list of Specgx Llc's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7691880 Methylphenidate solution and associated methods of administration and production 07 Oct, 2024 Expired
US5702725 Hydromorphone therapy 07 Jul, 2014 Expired
US5914131 Hydromorphone therapy 07 Jul, 2014 Expired


Given below is the list of recent legal activities going on the following drug patents of Specgx Llc.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 06 Oct, 2021 US7691880
Payment of Maintenance Fee, 8th Year, Large Entity 06 Oct, 2017 US7691880
Patent Issue Date Used in PTA Calculation 06 Apr, 2010 US7691880
Recordation of Patent Grant Mailed 06 Apr, 2010 US7691880
Issue Notification Mailed 17 Mar, 2010 US7691880
Dispatch to FDC 01 Mar, 2010 US7691880
Application Is Considered Ready for Issue 25 Feb, 2010 US7691880
Issue Fee Payment Verified 18 Feb, 2010 US7691880
Issue Fee Payment Received 18 Feb, 2010 US7691880
Mail Notice of Allowance 26 Jan, 2010 US7691880
Mail Examiner's Amendment 26 Jan, 2010 US7691880
Notice of Allowance Data Verification Completed 21 Jan, 2010 US7691880
Case Docketed to Examiner in GAU 21 Jan, 2010 US7691880
Interview Summary Record 14 Jan, 2010 US7691880
Disposal for a RCE / CPA / R129 10 Dec, 2009 US7691880


Specgx Llc's Family Patents

Specgx Llc drugs have patent protection in a total of 9 countries. It's US patent count contributes only to 27.3% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click below to unlock the full patent family tree.

Family Patents



Specgx Llc Drug List

Given below is the complete list of Specgx Llc's drugs and the patents protecting them.


1. Exalgo

Exalgo is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5702725 Hydromorphone therapy 07 Jul, 2014
(10 years ago)
Expired
US5914131 Hydromorphone therapy 07 Jul, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Exalgo's drug page


2. Methylin

Methylin is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7691880 Methylphenidate solution and associated methods of administration and production 07 Oct, 2024
(7 days ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Methylin's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List